170432 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines; Interleukins [IL] IL-12
USE OF MONOLITHIC ANION EXCHANGE CHROMATOGRAPHY AND LIGHT SCATTERING FOR QUANTIFYING EXTRACELLULAR VESICLES
#2METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#3COMPOSITIONS AND METHODS FOR ANALYSIS, DETECTION, AND TREATMENT OF MULTIPLE SCLEROSIS
#4METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#5Methods, Kits and Compositions for Assessing and Treating Interstitial Cystitis
#6TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#7NOVEL CYTOKINE-BASED THERAPIES AND METHODS
#8METHOD FOR EVALUATING QUALITY OF INDUCEMENT INHIBITORY-T-CELL FORMULATION
#9TREATMENT OF AGING FRAILTY COMPRISING ADMINISTERING BONE MARROW DERIVED MESENCHYMAL STEM CELLS
#10VAGUS NERVE STIMULATION PRE-SCREENING TEST
#11MOLECULAR SIGNATURES OF LONG-TERM COVID-19 AND TREATMENT THEREOF
#12INDIRECT HOMOGENEOUS MOBILITY SHIFT ASSAYS FOR THE DETECTION OF BIOLOGICS IN PATIENT SAMPLES
#13METHODS FOR PREDICTION OF ANTI-TNF ALPHA DRUG LEVELS AND AUTOANTIBODY FORMATION
#14PREDICTIVE LIQUID MARKERS FOR CANCER IMMUNOTHERAPY
#15BIOMARKERS FOR ASSESSING EXPLANT ORGAN VIABILITY
#16METHODS AND PRODUCTS FOR TREATMENT OF GASTROINTESTINAL DISORDERS
#17USE OF PERIPHERAL BLOOD PRO- AND ANTI-INFLAMMATORY CYTOKINE RATIOS AS MARKERS OF IMPLANTATION PRECEDING PREGNANCY
#18NOVEL CYTOKINES AND USE THEREOF
#19BIOMARKERS
#20Vagus nerve stimulation pre-screening test
#21COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#22Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#23DENDRITIC CELL POTENCY ASSAY
#24Treatment of cancers using PI3 kinase isoform modulators
#25BIOMARKER COMBINATION FOR IDENTIFICATION OF "AT-RISK" SUBJECTS FOR AKI
#26Biomarkers related to organ function
#27Methods for prediction of anti-TNF α drug levels and autoantibody formation
#28Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#29COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#30COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#31COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#32Methods and compositions for the diagnosis and treatment of cancer
#33Vagus nerve stimulation pre-screening test
#34Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
#35Use of IL-3, IL-33 and IL-12p40 as markers for characterization of respiratory infections by respiratory syncytial virus
#36Immune profiling and minimal residue disease following stem cell transplantation in multiple myeloma
#37METHODS OF TREATING WITH TUMOR MEMBRANE VESICLE-BASED IMMUNOTHERAPY AND PREDICTING THERAPEUTIC RESPONSE THERETO
#38TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#39Biomarker for diagnosing vascular diseases and the uses thereof
#40Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#41Methods for prediction of anti-TNFα drug levels and autoantibody formation
#42ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS
#43METHOD FOR PRODUCING AUTOLOGOUS TOLEROGENIC DENDRITIC CELLS (TOLDCS) WITH SPECIFIC ANTIGENS AND THEIR USE IN THE PREPARATION OF A MEDICAMENT USEFUL FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
#44Epitope recognized by anti-interferon gamma autoantibodies in patients with disseminated mycobacterial infections and the application therefor
#45METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILES
#46METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#47Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
#48Compositions and methods for modulating an immune response
#49Sample analysis systems and methods
#50Biomarkers related to organ function
#51METHODS FOR DIAGNOSIS OF CUTANEOUS T-CELL LYMPHOMA
#52Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#53Methods and compositions for the diagnosis and treatment of cancer
#54Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#55Process for assessing risk of substance administration
#56Biomarkers for the identification of liver damage
#57Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer
#58DETERMINATION OF EFFICIENT TIME(S) FOR CHEMOTHERAPY DELIVERY
#59BIOMARKERS FOR LOWER URINARY TRACT SYMPTOMS (LUTS)
#60Biomarkers for Tuberculosis and HIV/AIDS
#61METHODS OF MODULATING THE OX40 RECEPTOR TO TREAT CANCER
#62Therapeutic Use Of Probiotics
#63Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#64METHODS FOR DIAGNOSING DIABETES AND DETERMINING EFFECTIVENESS OF TREATMENTS
#65METHODS OF MODULATING THE OX40 RECEPTOR TO TREAT CANCER
#66Cd4+ Cd25+ T-cells activated to a specific antigen
#67METHODS AND COMPOSITIONS FOR ASSESSING IL-12 OR THE NEUTRALIZATION OF IL-12 IN A SAMPLE